ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Detection of Right Ventricular Dilation and Dysfunction by Transthoracic Echocardiography Predicts Renal Transplant Outcomes.

    F. Tinney Jr,1 S. Lazar,2 A. Naik,2 M. Samaniego-Picota,2 N. Bhave.2

    1Wayne State University School of Medicine, Detroit, MI; 2University of Michigan, Ann Arbor, MI

    Introduction: The prevalence of pulmonary hypertension (PHTN) among end stage renal disease (ESRD) patients on hemodialysis is approximately 40-50%. Right heart catheterization is the gold…
  • 2017 American Transplant Congress

    A Single Center Retrospective Review of Pediatric Kidney Transplant Outcomes According to Banff Grade and Cellular Rejection Treatment.

    J. Chen,1 R. Liverman,2 R. Garro,2,3 S. Jernigan,2,3 P. Winterberg.2,3

    1Morgan Stanley Children's Hospital, New York, NY; 2Children's Healthcare of Atlanta, Atlanta, GA; 3Department of Pediatrics, Emory University, Atlanta, GA

    Acute cellular rejection (ACR) remains a major cause of graft dysfunction and loss. There is limited data to provide guidance on optimal treatment strategies stratified…
  • 2017 American Transplant Congress

    The Outcome of 0 Mismatch Kidney in Pediatric Population with High Immunologic. The Impact of Induction Therapy. An Analysis of UNOS Database.

    V. Whittaker, M. Laftavi, Z. Acun, R. Gruessner, A. Gruessner.

    Surgery, State University New York, Syracuse, NY

    Background: 0 mismatch kidneys have superior outcomes in primary transplant recipient. We performed Analysis UNOS database to determine the outcome of high PRA transplant pediatric…
  • 2017 American Transplant Congress

    An Argument for Expanding the Simultaneous Liver and Kidney Transplant Criteria: Validity of the New UNOS Allocation Policy.

    S. Nagai,1 M. Safwan,1 K. Collins,1 M. Rizzari,1 D. Moonka,2 K. Brown,2 A. Patel,3 A. Yoshida,1 M. Abouljuod.1

    1Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; 2Gastroenterology, Henry Ford Hospital, Detroit, MI; 3Nephrology, Henry Ford Hospital, Detroit, MI

    Aim: According to the latest simultaneous liver-kidney transplant (SLK) allocation policy by UNOS, allocation of kidney is dependent on duration of low glomerular filtration rate…
  • 2017 American Transplant Congress

    Impact of Donor Genotype on Recipient Tacrolimus Pharmacokinetics: The Liver Matters.

    S. Tremblay,1 T. Fukuda,2 T. Mizuno,2 E. Woodle,1 B. Abu Jawdeh,1 A. Govil,1 U. Christians,3 J. Klawitter,3 A. Vinks,2 R. Alloway.1

    1U of Cinicnnati, Cincinnati; 2Cincinnati Children's, Cincinnati; 3iC42 Clinical Research, Colorado

    Tacrolimus (Tac) is a cornerstone immunosuppressant metabolized in the gut and liver, resulting in high intra/inter patient pharmacokinetic (PK) variability. Recipient genotype (RG) impacts tac…
  • 2017 American Transplant Congress

    HCV Eradication with DAA Therapy Should Be Attempted Prior to Liver Transplantation and Does Not Impact HCC Recurrence.

    J. Emamaullee, M. Bral, G. Meeberg, A. Montano-Loza, V. Bain, D. Bigam, N. Kneteman, A. Shapiro.

    University of Alberta, Edmonton, AB, Canada

    Background: Recent advances in the direct-acting antiviral (DAA) treatment of HCV have lead to high rates of HCV eradication, even in patients with decompensated cirrhosis.…
  • 2017 American Transplant Congress

    Timing of HLA Testing as a Means of Reducing Cost and Increasing Efficiency of Living Kidney Donation.

    E. Venniro, J. Taylor.

    Medicine, University of Rochester Medical Center, Rochester, NY

    Purpose: Creating an effective living kidney donor process can be a challenge for transplant centers. There needs to be a balance between efficiency, resources, patient…
  • 2017 American Transplant Congress

    Trends in Long-Term Outcomes of Kidney Transplantation in Australia and New Zealand.

    W. Lim,1 W.-C. Yeung,2 S. Campbell,3 S. Chadban,4 P. Clayton,5 C. Hawley,3 D. Johnson,3 S. McDonald,5 E. Pascoe,6 G. Wong,7 S. Badve.2

    1Sir Charles Gairdner Hospital, Perth, Australia; 2St George Hospital, Sydney, Australia; 3Princess Alexandra Hospital, Brisbane, Australia; 4Royal Prince Alfred Hospital, Sydney, Australia; 5University of Adelaide, Adelaide, Australia; 6University of Queensland, Brisbane, Australia; 7Westmead Hospital, Sydney, Australia

    Introduction: Surgical and medical advances have led to considerable improvement in short-term outcomes of kidney transplantation, with 1-year graft and patient survival approaching 100%. However,…
  • 2017 American Transplant Congress

    Novel Classification of Membranoproliferative Glomerulonephritis Pattern of Injury in Renal Allograft Based on Immunofluorescence Microscopy: Precise Diagnosis and Prognosis Analysis.

    J. Wen, X. Li, M. Zhang, F. Xu, X. Ni, J. Chen, Z. Tang, Z. Liu.

    National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University, Nanjing, China

    Background: Membranoproliferative glomerulonephritis (MPGN) after renal transplantation is a pattern of injury with heterogenous etiologies. Novel classification of MPGN based on the Immunofluorescence microscopy was…
  • 2017 American Transplant Congress

    Use of Hepatitis C Infected Organs for Kidney Transplantation: A Cost-Effective Analysis.

    B. Kiberd,1 K. Doucette,2 K. Tennankore.1

    1Dalhousie University, Halifax, NS, Canada; 2University of Alberta, Edmonton, AB, Canada

    Given that Hepatitis C (HCV) can be cured, organs from HCV+ deceased donors might be used even in HCV- recipients. However HCV treatment is expensive.…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences